Medico Remedies Ltd Share Price & Stock Analysis

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India.

Key Metrics

Current Price	₹47.55
Market Cap	₹395 Cr
Sector	Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-Industry	Pharmaceuticals > Pharmaceutical Products
P/E Ratio	30.1
Return on Equity	19.02%
52-Week Range	₹30.22 – ₹56.88
Beta (1Y)	0.26

Business Segments

1. Pharmaceuticals-100%

Peer Companies

• Abbott India Ltd.
• Ajanta Pharma Limited
• Astrazeneca Pharma India Ltd.
• Pfizer Ltd.
• Eris Lifesciences Ltd
• Caplin Point Laboratories Ltdte
• Marksans Pharma Ltd.
• Strides Pharma Science Limited (Star)

Frequently Asked Questions

What is the current share price of Medico Remedies Ltd?

Medico Remedies Ltd is trading at ₹47.55, with a market capitalisation of ₹395 Cr.

Which sector does Medico Remedies Ltd belong to?

Medico Remedies Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).

What are the key financial ratios of Medico Remedies Ltd?

Medico Remedies Ltd has a P/E of 30.1 and a return on equity of 19.02%.